These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6060734)

  • 1. Testosterone and fibrinolytic activity.
    Winther O
    Scand J Clin Lab Invest Suppl; 1967; 99():207-10. PubMed ID: 6060734
    [No Abstract]   [Full Text] [Related]  

  • 2. [Testosterone and the prostate gland].
    Winther O
    Nord Med; 1970 May; 83(20):624-6. PubMed ID: 5426430
    [No Abstract]   [Full Text] [Related]  

  • 3. Testosterone and blood fibrinolytic activity.
    Winther O
    Lancet; 1965 Apr; 1(7389):823. PubMed ID: 4165110
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal treatment of arterial insufficiency in the lower extremities.
    Albrechtsen O; Barfod B; Barfod E; Laursen NP; Nordentoft B; Yde H
    Dan Med Bull; 1972 Jul; 19(5):157-9. PubMed ID: 5049043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Testosterone and fibrinolytic activity. A study of patients with ischemic disorders of the legs. Preliminary report].
    Winther O
    Ugeskr Laeger; 1965 Sep; 127(36):1112-5. PubMed ID: 5869539
    [No Abstract]   [Full Text] [Related]  

  • 6. [Taurine in the therapy of obliterating arteriopathy of the lower extremities. I. Clinical results in various evolutive phases].
    Zanelli G; Ferrero S; Patrone P
    Minerva Cardioangiol; 1971 Nov; 19(11):605-15. PubMed ID: 5128422
    [No Abstract]   [Full Text] [Related]  

  • 7. [Testosterone in arterial insufficiency of the lower extremities].
    Hentzer E; Madsen PC
    Nord Med; 1966 Nov; 76(45):1307-12. PubMed ID: 5926103
    [No Abstract]   [Full Text] [Related]  

  • 8. [Assessment of the clinical effectiveness of actihaemyl in Fontaine stage IIb intermittent claudication].
    Horsch S; Claeys L; Diehm C; Rieger H; Cachovan M; Baitsch C
    Vasa Suppl; 1992; 37():64-5. PubMed ID: 1481105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Vasodilator drugs and obliterating arterial diseases of the lower extremities].
    Larsen OA; Lassen NA
    Ugeskr Laeger; 1967 Sep; 129(36):1168-71. PubMed ID: 5598859
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative treatment of arterial insufficiency in the legs (1)].
    Lund F
    Lakartidningen; 1968 Apr; 65(14):1435-48. PubMed ID: 4913094
    [No Abstract]   [Full Text] [Related]  

  • 11. Naftidrofuryl (Praxilene) in peripheral vascular disease.
    Drug Ther Bull; 1979 Oct; 17(21):83-4. PubMed ID: 498948
    [No Abstract]   [Full Text] [Related]  

  • 12. [The peripheral blood flow after vasodilatating procedures].
    Landgard H
    Nord Med; 1971 Jun; 85(22):696. PubMed ID: 5088271
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arterial insufficiency in the lower extremities treated with drugs].
    Genster HG; Oram V
    Ugeskr Laeger; 1971 Feb; 133(6):244-6. PubMed ID: 4926100
    [No Abstract]   [Full Text] [Related]  

  • 14. Ancrod: clinical indications and methods of use.
    Wright JG; Geroulakos G
    Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of 1-(4-oxyphenyl)-1-oxy-2-n-butylaminoethane sulfate on peripheral vascular diseases].
    Giulini SM; Agus GB; De Cristoforo A
    Minerva Cardioangiol; 1973 Jun; 21(6):434-8. PubMed ID: 4146376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of arterial insufficiency in the lower extremities by intra-arterial injection].
    van der Molen HR
    Phlebologie; 1987; 40(1):157-69. PubMed ID: 3575431
    [No Abstract]   [Full Text] [Related]  

  • 17. Peripheral vasodilator drugs.
    Br Med J; 1969 Jul; 3(5661):38-40. PubMed ID: 5787285
    [No Abstract]   [Full Text] [Related]  

  • 18. Haemorheological therapy.
    Dormandy J; Postlethwaite J; Goyle K
    Bibl Anat; 1977; (16 Pt 2):481-3. PubMed ID: 603589
    [No Abstract]   [Full Text] [Related]  

  • 19. [Increasing transcutaneous PO2 in arteriopathies during treatment with PGE1 alpha-cyclodextrin].
    Belcaro G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):37-43. PubMed ID: 10658443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local application of thymoxamine in peripheral vascular disease.
    Turner P; Harrison J; Schoenfeldt R
    Lancet; 1969 Jun; 1(7608):1238-9. PubMed ID: 4182414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.